Mycobacterial disease Flashcards

(34 cards)

1
Q

Describe where non-tuberculous mycobacteria can be found, and how it spreads

A
  • Non-tuberculous mycobacteria is environmental and atypical - found in lakes/water and soil
  • Ubiquitous in nature
  • Varying spectrum of pathogenicity
  • No person-to-person transmission
  • Commonly resistant to classical anti-TB prescriptions
  • May be founf colonizing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Who is at risk of developing slow-growing Non-tuberculous mycobacteria?
  2. What are the different types of slow growing NTM and where are they found?
A
  1. Immunocompetent and immunocompromised (at risk of disseminated infection)

2.

  • Mycobacterium avium intracellulare/ M.avium complex
  • M.marinum - swimming pool granuloma
  • M.ulcerans - Skin lesions e.g. Bairnsdale ulcer, Buruli ulcer - causing a chronic progressive painless ulcer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What are the different ‘rapid-growing’ NTM?
  2. What do they cause?
A

1.

  • M.abscessus
  • M.chelonae
  • M.fortuitum

2.

  • Skin and soft tissue infections
  • In hospital settings, isolated BCs - vascular catheters and other devices
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the diagnosis of Non-tuberculous mycobacteria from the 2007 American thoracic society guidelines

A
  • Clinical - pulmonary symptoms, nodular/cavitary opacities, multifocal bronchiectasis with multiple small nodules
  • Exclusion of other diagnoses
  • Microbiologic:
    • Positive culture >1 sputum samples
    • OR +ve BAL
    • OR +ve biopsy with granulomata
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the treatment of Non-tuberculous mycobacteria?

A
  • Susceptibility testing results may not reflect clinical usefulness
  • MAI:
    • Clarithryomycin/azithromycin
    • Rifampicin
    • Ethamnutol
    • +/- Amikacin/streptomycin
  • Rapid-growing NTM
    • Based on susceptibility testing, usually macrolide-based
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two types of mycobacterium leprae?

A
  • Paucibacillary tuberculoid
  • Multibacillary lepromatous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the epidemiology of mycobacterium tuberculosis

A
  • Multi-system disease
  • Common worldwide
    • 2nd most common cause of death by infectious agent
    • 2 million deaths each year
  • Increasing prevalence since 1980s
    • Most common opportunistic infection in HIV
    • Immigration
  • 9000 cases reported per annum in UK
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the transmission of TB?

A
  • Droplet nuclei/airborne
    • <10um particles
    • Suspended in air
    • Reach lower airway macrophages
  • Infectious dose 1-10 bacilli
  • 3000 infectious nuclei
    • cough
    • talking for 5 minutes
  • Air remains infectious for 30 minutes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can TB be prevented?

A
  • Detection of cases
  • Treatment of TB in a timely manner
  • Prevention of transmission
    • PPE
    • Negative pressure isolation
  • Optimisation of susceptible contacts
    • Address risk factors
    • Vaccination
      • Bacille Calmette-Guerin (BCG): Live attenuated M.bovis strain
      • Given to babies in high prevalence communities (only since 2005)
      • 70-80% effectiveness in preventing severe childhood TB
      • Protection wanes
      • Little evidence in adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the natural history of pulmonaryTB?

A
  • Primary TB
    • Usually asymptomatic
    • Ghon focus/complex
    • Limited by CMI
    • Rare allergic reactions include EN
    • Occassionally disseminated/miliary
  • Latent TB
  • Reactivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. Describe post-primary TB
  2. What are the risk factors for reactivation of TB?
A
  1. Post-primary TB:
  • reactivation or exogenous re-infection
  • > 5 years after primary infection
  • 5-10% risk per lifetime
  1. Risk factors for reactivation
  • Immunosuppression
  • Chronic alcohol excess
  • Malnutrition
  • Ageing

Clinical presentation - pulmonary or extra-pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the radilogical features of pulmonary TB

A
  • Caseating granulomata
    • Lung parenchyma
    • Mediastinal Lymph nodes
  • Commonly upper lobe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe what can develop in people with Extra-pulmonary TB

A
  • Lymphadenitis
    • AKA scrofula
    • Cervical lymph nodes most commonly
    • Abscesses and sinuses
  • Gastrointestinal
    • Swallowing of tubercules
  • Peritoneal
    • Ascitic or adhesive
  • Genitiurinary
    • Slow progression to renal disease
    • Subsequent spreading to lower urinary tract
  • Bone and joint
    • Haematogenous spread
    • Spinal TB most common
    • Pott’s disease
  • Miliary TB:
    • Millet seeds on CXR
    • Progressive disseminated haematogenous TB
    • Increasing due to HIV
  • Tuberculous meningitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does this image show?

A

Millet seeds, a signs of Miliary TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is spinal TB known as?

A

Pott’s disease

17
Q

Describe the demographics and risk factors for TB

A
  • Non-UK born/recent migrants
    • south asia 54.8%
    • sub-saharan africa 29.5%
  • HIV or other immunocompromise
  • Homeless
  • Drug users, prison
  • Close contacts
  • Young adults
18
Q

What is the presentation of TB?

A
  • Fever
  • Weight loss 74%
  • Night sweats 55%
  • Pulmonary symptoms
    • cough 80%
    • haemoptysis 6-37%
  • Malaise 68%
  • Anorexia
19
Q

What are important questions to ask for someone who you suspect has TB?

A
  • Ethnicity
  • Recent arrival or travel
  • Contacts with TB
  • BCG vaccination
  • Non-specific examination findings
20
Q

What investigations should be performed in suscpected TB?

A
  • CXR and other radiology
  • Spuum x3 - induced sputum
  • Bronchoscopy
  • Biopsies
  • EMU

stain for AAFBs ‘smear’

culture

NAAT

Histology

Tuberculin skin test

IGRAs

21
Q

What does the image show?

A

Mediastinal lymph node

22
Q

Describe a smear for TB

A
  • Uses sputum
    • 60% sensitivity
    • Increases with more samples
  • Gastric aspirates in kids
  • Other specimens centrifuged
  • Rapid
  • Operator dependent
23
Q

Summarise different bacteriological examinations for TB

24
Q

Describe the use of cultures for diagnosing TB

A
  • Culture is gold standard
  • Solid and liquid culture systems
  • Takes up to 6 weeks - less with modern automated systems
25
What do tuberculin skin tests show?
* Tuberculin skin test shows previous exposure to mycobacteria * 2 units tuberculin * Delayed type hypersensitivity reaction (type 4) * Cross-reacts with BCG * Poor sensitivity * HIV, age, immunosuppressants * Overwhelming TB
26
Describe the use of interferon gamma release assays (IGRAs)
* Detection of antigen-specific IFN-gamma production * ELISpot * Quantiferon * No cross reaction with BCG * Cannot distinguish latent and active TB * Similar issues with sensitivity and specificity
27
What are the first line medications for TB?
* Rifampicin * Isoniazid * Pyrazinamide * Ethambutol RIPE
28
What are the second line medications for TB?
* Quinolones (moxifloxacin) * Injectables - capreomycin, kanamycin, amikacin * Ethionamide/prothioamide * Cycloserine * PAS * Linezolid * Clofazamine
29
The treatment for TB is RIPE, a multi-drug therapy. Describe the side effects of each of the antibiotics
* Rifampicin * Raised transaminases and induces cytochrome P450 * Orange secretions * Isoniazid * Peripheral neuropathy * Hepatotoxicity * Pyrazinamide * Hepatotoxicity * Ethambutol * Visual disturbance
30
Describe the duration of treatment for TB
* 3 or 4 drugs of RIPE for 2/12 * Then Rifampicin and Isonazid 4/12 * 10/12 if CNS TB * Cure rate 90%
31
Describe Multidrug resistance TB * What is it against? * What has caused it?
* Multidrug resistance TB - resistant to rifampicin and isonazid * Extremely drug resistant TB * Also resistant to fluoroquinolones and at least 1 injectable * Spontaneous mutation + inadequate treatment * Liklihood increased * Previous TB prescription * HIV positive * Known contact of multi-drug resistant TB * Failure to respond to conventional Rx * \> 4 months smear +\>5 months culture +ve * 4/5 drug regimen, longer duration * Quinolones, aminoglycosides, PAS, cycloserine and ethionamide
32
Describe the following challenges with having TB and HIV when it comes to diagnosis of TB: 1. Clinical history 2. Chest X ray 3. Smear microscopy and culture 4. Tuberculin skin test 5. Sensitivity of interferon gamma release assays for active tuberculosis
1. Clinical history * Less likely to be classical * Symptoms and signs are often absent in population with low CD4 count 2. Chest X-ray * More likely extrapulmonary * X-ray changes variable 3. Smear microscopy and culture * Less sensitive 4. Tuberculin skin test * More likely to be negative 5. Sensitivity of IGRAs for active TB * Quantiferon - reduced * T SPOT - reduced
33
What are the challenges in TB and HIV when it comes to treatment?
* Timing of treatment initiation * Drug interactions * Overlapping toxicity * Duration of treatment - adherence * Health care resources
34
Name two novel diagnostic tests
* IGRAs - interferon gamma release assays * NAATs - Nucleic acid amplification tests